These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26710878)

  • 21. Delirium and cerebrospinal fluid S100B in hip fracture patients: a preliminary study.
    Hall RJ; Ferguson KJ; Andrews M; Green AJ; White TO; Armstrong IR; MacLullich AM
    Am J Geriatr Psychiatry; 2013 Dec; 21(12):1239-43. PubMed ID: 23602305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expressions of brain-derived neurotrophic factor (BDNF) in cerebrospinal fluid and plasma of children with meningitis and encephalitis/encephalopathy.
    Morichi S; Kashiwagi Y; Takekuma K; Hoshika A; Kawashima H
    Int J Neurosci; 2013 Jan; 123(1):17-23. PubMed ID: 22900512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum S100B levels in patients with cerebral and extracerebral infectious disease.
    Undén J; Christensson B; Bellner J; Alling C; Romner B
    Scand J Infect Dis; 2004; 36(1):10-3. PubMed ID: 15000552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury.
    Kleindienst A; Meissner S; Eyupoglu IY; Parsch H; Schmidt C; Buchfelder M
    Acta Neurochir Suppl; 2010; 106():247-50. PubMed ID: 19812958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers of Brain Damage: S100B and NSE Concentrations in Cerebrospinal Fluid--A Normative Study.
    Hajduková L; Sobek O; Prchalová D; Bílková Z; Koudelková M; Lukášková J; Matuchová I
    Biomed Res Int; 2015; 2015():379071. PubMed ID: 26421286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical significance of neutrophilic pleocytosis in cerebrospinal fluid in patients with viral central nervous system infections.
    Jaijakul S; Salazar L; Wootton SH; Aguilera E; Hasbun R
    Int J Infect Dis; 2017 Jun; 59():77-81. PubMed ID: 28435023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid beta 2-microglobulin in neonates with central nervous system infections.
    García-Alix A; Martín-Ancel A; Ramos MT; Salas S; Pellicer A; Cabañas F; Quero J
    Eur J Pediatr; 1995 Apr; 154(4):309-13. PubMed ID: 7607283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting outcome after severe brain injury in risk neonates using the serum S100B biomarker: results using single (24 h) time-point.
    Sofijanova A; Piperkova K; Al Khalili D
    Prilozi; 2012; 33(1):147-56. PubMed ID: 22952101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.
    Shore PM; Berger RP; Varma S; Janesko KL; Wisniewski SR; Clark RS; Adelson PD; Thomas NJ; Lai YC; Bayir H; Kochanek PM
    J Neurotrauma; 2007 Jan; 24(1):75-86. PubMed ID: 17263671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoinductive effect of cerebrospinal fluid from brain-injured patients.
    Gautschi OP; Toffoli AM; Joesbury KA; Skirving AP; Filgueira L; Zellweger R
    J Neurotrauma; 2007 Jan; 24(1):154-62. PubMed ID: 17263679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.
    Christo PP; Vilela Mde C; Bretas TL; Domingues RB; Greco DB; Livramento JA; Teixeira AL
    J Neurol Sci; 2009 Dec; 287(1-2):79-83. PubMed ID: 19782379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum and CSF biomarkers in acute pediatric neurological disorders.
    Shiihara T; Miyake T; Izumi S; Sugihara S; Watanabe M; Takanashi J; Kubota M; Kato M
    Brain Dev; 2014 Jun; 36(6):489-95. PubMed ID: 23850003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid lactate concentration and bacterial encephalitis diagnosis.
    Maillet M; De Broucker T; Mailles A; Bouzat P; Stahl JP; ;
    Med Mal Infect; 2018 Sep; 48(6):396-402. PubMed ID: 29914776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.
    Schmidt FM; Mergl R; Stach B; Jahn I; Schönknecht P
    World J Biol Psychiatry; 2015 Feb; 16(2):106-13. PubMed ID: 25264292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of S100B and Tau protein concentrations in the cerebrospinal fluid for the differential diagnosis of bacterial meningitis: a retrospective analysis.
    Jung K; Goerdt C; Lange P; Blocher J; Djukic M; Gerber J; Spreer A; Nau R; Otto M; Schmidt H
    Eur Neurol; 2011; 66(3):128-32. PubMed ID: 21865761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological deficit is predicted by S100B in children after cardiac surgery.
    Bar-Yosef O; Greidinger D; Iskilova M; Hemi R; Tirosh T; Vardi A
    Clin Chim Acta; 2018 Jun; 481():56-60. PubMed ID: 29499197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
    Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
    Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males.
    da Rocha AB; Schneider RF; de Freitas GR; André C; Grivicich I; Zanoni C; Fossá A; Gehrke JT; Pereira Jotz G; Kaufmann M; Simon D; Regner A
    Clin Chem Lab Med; 2006; 44(10):1234-42. PubMed ID: 17032136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, biochemical, and neuroimaging findings predict long-term neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection.
    Alarcon A; Martinez-Biarge M; Cabañas F; Hernanz A; Quero J; Garcia-Alix A
    J Pediatr; 2013 Sep; 163(3):828-34.e1. PubMed ID: 23587436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.
    Gonzćlez-Mao MC; Repáraz-Andrade A; Del Campo-Pérez V; Alvarez-García E; Vara-Perez C; Andrade-Olivié MA
    Clin Lab; 2011; 57(7-8):587-97. PubMed ID: 21888023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.